In this report we evaluate the anti-inflammatory effect of a variety of Lactobacillus spp. isolated from human gastric biopsies of dyspeptic patients. These lactobacilli were previously shown to secrete factors that inhibit tumor necrosis factor production from human monocytoid cells in vitro. Conditioned media from these lactobacilli were tested for the ability to modulate Helicobacter pylori-induced interleukin-8 (IL-8) production in AGS gastric epithelial cells. Out of 26 Lactobacillus spp. isolated from urease-negative patients thought not to harbor H. pylori, five significantly inhibited IL-8 production. The IL-8-inhibitory lactobacilli were identified as L. casei or L. paracasei, L. plantarum, L. rhamnosus, and L. salivarius and had no antagonistic effects on H. pylori growth. Our findings suggest potential candidates of Lactobacillus for further investigation of their beneficial effects on H. pylori-infected patients.
Introduction
Helicobacter pylori is a Gram-negative bacterial pathogen that infects the stomach of humans worldwide. Persistent infection with H. pylori results in a gastric inflammatory response, leading to the development of gastroduodenal diseases like chronic atrophic gastritis, gastric and duodenal ulcers, and gastric cancer.
1,2 H. pylori infection induces the production of several inflammatory mediators, including interleukin-8 (IL-8), [3] [4] [5] which is a potent neutrophil chemotactic and activating agent 6, 7 and is associated with disease severity. 8, 9 Less than 80% of H. pylori infections are eradicated with standard triple therapy, [10] [11] [12] and the eradication rate is less than 60% if clarithromycin-resistant H. pylori is present. 13, 14 Even with more aggressive therapy, cases of clarithromycin-resistant H. pylori continue to result in unsatisfactory eradication rates. 15 A potential solution to declining eradication rates of H. pylori infection is the administration of probiotic organisms. Others have demonstrated probiotics to be useful adjuncts in the treatment of H. pylori infection, resulting in higher eradication rates, reduction of severity and activity of gastritis, and reduction of antibiotic-associated side effects.
Materials and methods
Bacterial strains, culture conditions, and preparation of Lactobacillusconditioned media Lactobacillus spp. were routinely grown on de Man, Rogosa, Sharpe (MRS) agar (Becton Dickinson, Sparks, MD) anaerobically (10% CO 2 , 10% H 2 , and 80% N 2 ) in an anaerobic chamber (Concept Plus, Ruskinn Technology Ltd, Bridgend, UK) at 37°C. Lactobacillus-conditioned media (LCM) were prepared as previously described. 19 Briefly, lactobacilli were cultured as stated previously for 24 hours. The optical density of each culture was determined at 600 nm (OD 600 ) by spectrophotometery (Bio-Rad Smart Spec TM Plus, Bio-Rad Laboratories Inc, Hercules, CA), adjusted to an OD 600 0.1 in MRS broth, and cultured as stated previously for 48 hours. Culture supernatant was collected by centrifugation at 4000 × g for 10 minutes at 4°C, and the collected supernatant was filtered through a 0.22 µm filter (Minisart, Sartorius Stedim Biotech GmbH, Goettingen, Germany). Filtered supernatant was concentrated in a Savant SpeedVac (Savant instruments, Farmingdale, NY) and then resuspended in an equal volume of RPMI 1640 medium (Gibco-Invitrogen, Carlsbad, CA) for further testing with AGS cells. The conditioned media were stored at -20°C until further analysis.
H. pylori ATCC 43504 was grown on Columbia blood agar (Oxoid, Hampshire, UK) supplemented with 7% (v/v) horse serum (Gibco New Zealand Ltd, Auckland, New Zealand) and 7% (v/v) sheep blood at 37°C for 48 hours under microaeorphilic conditions (6-12% O 2 , 5-8% CO 2 ) using MGC Anaero Pack-Micro Aero boxes (Mitsubishi Gas Chemical Company, Inc, New York, NY). Bacterial cells were then transferred to, and resuspended in, antibioticfree RPMI medium. The bacterial suspension was adjusted to the density of No. 6 McFarland standard and used in the coculture assay.
ThP-1 monocytoid cell culture and bioassay for TnF activity
Monocytoid cell culture and in vitro bioassays were performed as stated previously. 18 Briefly, THP-1 human monocytoid cells (ATCC TIB-202, Manassas, VA) were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (Gibco-Invitrogen) in 96-well flat-bottomed tissue culture plates (Nunclon D, Roskilde, Denmark) and incubated at 37°C in a humidified 5% CO 2 incubator. THP-1 cells (2.5 × 10 5 cells/mL) were incubated with conditioned media (5% v/v) alone or in combination with purified LPS (100 ng/mL) from Escherichia coli serotype O127:B8 (Sigma-Aldrich, St Louis, MO) for 3.5 hours at 37°C. Supernatants were collected from individual wells by centrifugation at 4°C and assayed for TNF with human TNF-specific sandwich quantitative enzyme-linked immunosorbent assay (DuoSet, R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
Ags gastric epithelial cell culture AGS human gastric adenocarcinoma epithelial cells (ATCC CRL-1739) were obtained from the American Type Culture Collection (Manassas, VA). AGS cells were cultured as a monolayer (.80% confluence) in RPMI 1640 medium supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Gibco-Invitrogen) at 37°C and 5% CO 2 atmosphere for 48 hours. Adherent cells were detached from the flask with 0.25% (v/v) trypsin in 1 mM EDTA (Gibco-Invitrogen) at 37°C for 7-10 minutes. Detached cells were suspended in RPMI medium supplemented with 10% heat-inactivated fetal bovine serum (Gibco-Invitrogen), and the cell suspension was used for coculture assay.
Bioassay for IL-8 activity in Ags gastric epithelial cells AGS cell suspensions were seeded at a density of 1.0 × 10 5 cells/mL (20,000 cells per well) in a volume of 200 µL per well of a 96-well flat-bottomed tissue culture plate (Nunclon D) and preincubated as described previously. After 24 hours of incubation, the culture supernatant was replaced with 200 µL of fresh RPMI. Cells were exposed to 5% (v/v) conditioned media alone or in combination with 3 × 10 7 colonyforming unit (CFU)/mL viable H. pylori ATCC 43503 (6.0 × 10 6 CFU per well with a multiplicity of infection of 300). The assay plate was incubated under 5% CO 2 at 37°C for 24 hours, and cell culture supernatants were collected by centrifugation at 125 × g for 7 minutes at 4°C. The IL-8 level in the culture supernatant was determined using a Quantikine Human IL-8 Immunoassay Kit (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions. 
Cell viability assay

H. pylori growth inhibition by lactobacilli
Disc diffusion method IL-8-inhibitory strains of lactobacilli were tested for antagonistic activity against H. pylori ATCC 43504 as follows. Sterile 6 mm membrane discs (Whatman, Maidstone, UK) were soaked in cell-free Lactobacillus-conditioned media at room temperature for at least 1 hour. H. pylori was applied to Columbia blood agar, and discs containing Lactobacillus-conditioned media were subsequently placed atop the agar. After incubation under microaerophilic conditions at 37°C for 72 hours, a clear zone around a disc was scored positive for antagonistic activity against the growth of H. pylori. A disc soaked with MRS broth was used as a negative control. Conditioned medium from L. salivarius T59, our laboratory strain that can antagonize the growth of H. pylori, was used as a positive control. The experiments were performed in triplicate.
spot-overlay method
Antagonism of H. pylori growth was also assessed using a spot-overlay method as previously described. 20 Briefly, Lactobacillus spp. were cultured anaerobically at 37°C for 24 hours in brain heart infusion (BHI) broth (Oxoid), spotted onto BHI agar, and incubated anaerobically at 37°C for 48 hours. The spotted plate of Lactobacillus was then overlaid with soft agar (0.75% agar) containing 72-hour culture of H. pylori in BHI broth supplemented with 10% horse serum at a final concentration of 1 × 10 8 CFU/mL. The overlain plate was incubated microaerophilically at 37°C for 72 hours. A clear zone around each spot of Lactobacillus was scored as positive. L. salivarius T59 was included as a positive control for inhibition of H. pylori. The experiments were performed in triplicate.
statistical analysis
All experiments were performed three times in triplicate, and the results were reported as mean value with standard deviation (SD). The data were analyzed using the Student's t-test with one-tailed distribution and were considered statistically significant at a P value , 0.05.
Results
IL-8 production by H. pylori-stimulated
Ags gastric epithelial cells and immunomodulatory effects of gastric biopsy-derived Lactobacillus spp.
Twenty-six Lactobacillus spp. isolated from gastric biopsies of dyspeptic patients were selected on the basis that they are able to inhibit TNF production in LPS-activated THP-1 monocytoid cells but do not stimulate TNF production in high magnitude by themselves 18 (Table 1, Figure 1 ). These isolates were tested for the ability to inhibit IL-8 production in H. pylori-stimulated AGS gastric epithelial cells. AGS gastric epithelial cells secreted increased amounts (.15-fold) of IL-8 after 24 hours of coincubation with H. pylori compared with cells exposed to bacterial media (MRS) alone. Cell-free conditioned media of five Lactobacillus spp. significantly inhibited IL-8 production in various magnitudes, whereas those of 14 lactobacilli did not (Figure 2 Figure 3 . In the absence of H. pylori, the conditioned media of these five Lactobacillus spp. did not significantly stimulate IL-8 production.
IL-8-inhibitory Lactobacillus spp. did not inhibit the growth of H. pylori
To investigate whether IL-8-suppressive activity of these five Lactobacillus spp. resulted from the inhibition of H. pylori growth, we tested the antagonism of H. pylori growth by using the LCM disc diffusion and spot-overlay methods. It was found that these lactobacilli did not inhibit the growth of H. pylori, as shown in Table 2 .
Discussion
The human gastrointestinal microbiota are an important source of potential probiotics for human use. The human stomach harbors diverse microbial flora, including lactobacilli, as determined by 16S rRNA gene sequencing, 21 and different Lactobacillus spp. have been cultivated from gastric biopsies of healthy humans. 22, 23 These gastric lactobacilli could be promising candidate probiotics for H. pylori-associated diseases. Although our gastric Lactobacillus spp. were isolated from dyspeptic patients, they have the ability to inhibit TNF production from LPSactivated THP-1 monocytoid cells. 18 In the present study, 25 In addition, live L. gasseri OLL2716 (LG21), as well as its spent culture supernatant, was reported to suppress H. pylori-induced IL-8 production from both MKN45 gastric epithelial cells and the gastric mucosa of H. pylori-infected patients. 26 The fact that different strains of the same species of our gastric lactobacilli varied in their ability to suppress IL-8 production highlights the strain specificity of this inhibitory property. IL-8 secreted by gastric epithelial cells of H. pylori-infected patients stimulates the migration of neutrophils and lymphocytes to the inflamed mucosa, resulting in more inflammatory pathology. 2 Neutrophils and mononuclear cells recruited to patients' mucosa induce nitric oxide synthase to produce mutagenic nitric oxides that may result in DNA damage and subsequent apoptosis in the gastric mucosa.
27 Therefore, our IL-8-inhibitory gastric Lactobacillus may be beneficial for the reduction of mucosal inflammation.
Probiotic Lactobacillus are known to suppress H. pyloriinduced IL-8 production in vitro by different mechanisms, such as the inhibition of the TLR4 pathway, 25 acid production, 26 ,28 activation of suppressor of cytokine signaling, 29 and inhibition of expression and function of the Cag type IV secretion system. 28 Our isolated Lactobacillus did not inhibit the growth of H. pylori as shown by either the disc diffusion or spot-overlay assays. In addition, IL-8 production was not affected by acidity, because the pH B13  XB68  B90  XB94  B106  B7  B8  B21  XB41  XB45  B47  XB48  XB58  B64  B60  B67  B73  XB77  B87  XB95  XB96  B103  XB7  B23  B36 B90  XB94  B106  B7  B21  XB41  XB45  B47  XB48  XB58  B60  XB77  XB95  XB96  B103  XB7  B23  B36 Of the five IL-8-suppressive lactobacilli identified in the present study, L. salivarius is considered indigenous (autochthonous) to humans, whereas the remaining four species are considered transient (allochthonous). 30 We have identified indigenous and transient Lactobacillus species with anti-inflammatory activity. These isolates are potential candidates for the treatment of H. pylori-induced gastric illness and deserve further characterization of their probiotic mechanisms. 
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